已经得到个称赞     给我点赞
  • 硕士生导师
  • 入职时间:2024-09-11
  • 所在单位:湘雅公共卫生学院
  • 学历:研究生(博士后)
  • 办公地点:湖南省长沙市岳麓区桐梓坡路172号中南大学湘雅公共卫生学院
  • 性别:
  • 联系方式:yangsongchun@csu.edu.cn
  • 学位:博士学位
  • 在职信息:在职
  • 毕业院校:北京大学
  • 学科:公共卫生与预防医学
论文成果
当前位置: 中文主页 >> 论文成果
The Impact of Lifestyle Factors on Cardiometabolic Comorbidities and Mortality of Psoriatic Diseases: A Multi-State Model Analysis
  • 点击次数:
  • DOI码:10.1016/j.jaad.2025.05.1395
  • 发表刊物:J Am Acad Dermatol
  • 摘要:Background: The role of lifestyle factors in the progression of psoriatic diseases (PDs) and cardiometabolic diseases (CMDs) remains underexplored. Objective: To assess the impact of lifestyle factors on transitions from a disease-free state to PDs, CMDs, their multimorbidity, and death. Methods: We analyzed 379,874 UK Biobank participants. Lifestyle factors included smoking status, body mass index (BMI), physical activity, and diet. An ideal lifestyle was defined as never smoking, BMI < 25 kg/m2, and adequate physical activity. Multistate models were employed to evaluate their impacts on different transitions. Results: Over 12.1 years, 2500 PD and 34,619 CMD incident events occurred. An ideal lifestyle showed protective effects on PD incidence among disease-free individuals, CMD incidence and all-cause mortality among PD patients, and all-cause mortality among patients with PD and CMD multimorbidity; the corresponding hazard ratios (95% confidence intervals) were 0.43 (0.36-0.51), 0.40 (0.31-0.53), 0.50 (0.31-0.81), and 0.64 (0.39-1.05), compared with participants who were ever-smokers, BMI ≥ 25 kg/m2, and with inadequate physical activity. Ideal lifestyle added up to 5.3 years of life expectancy in PD participants. Limitations: No verification in other ascertained population. Conclusions: Lifestyles are modifiable determinants and nonpharmaceutical strategies for preventing cardiometabolic comorbidities and mortality of PDs.
  • 备注:共同第一作者(2/2)
  • 论文类型:期刊论文
  • 论文编号:PMID: 40383272
  • 文献类型:J
  • 卷号:93
  • 期号:3
  • 页面范围:715-723
  • 是否译文:
  • 发表时间:2025-09-01
  • 收录刊物:SCI